ClinicalTrials.gov
public full text
Public Domain
A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer Patients
The purpose of the study is to determine the effect of Egalet® Morphine once daily compared to MST Continus twice daily on pain intensity and use of rescue medication for break through pain after 2 weeks of treatment in patients with pain due to cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Oxcarbazepine Plus Morphine in Patients With Refractory Cancer Pain#1161374
- A Comparison of Morphine and Morphine Plus Dexmedetomidine in Chronic Cancer Pain#848273
- Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain#1170960
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2#886460
- Individualized Pharmaceutical-care in Outpatients With Cancer Pain#876292
Record · ID 850829
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive